Samsung Biologics Co.,Ltd.
207940
Classement en actions
#498
Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon,... Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.
Prix de l'action
$1,028.49
Capitalisation boursière
$47.88B
Changement (1 jour)
-3.67%
Changement (1 an)
-18.37%
Pays
KR
Échange Samsung Biologics Co.,Ltd. (207940)
Catégorie
Healthcare
Nombre d'actions en circulation pour Samsung Biologics Co.,Ltd. (207940)
Nombre d'actions en circulation au September 2026: 46.61M
Selon les derniers rapports financiers et le cours de l'action de Samsung Biologics Co.,Ltd., le nombre actuel d'actions en circulation est de 46.61M. À la fin de December 2024, l'entreprise avait 46.29M actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de Samsung Biologics Co.,Ltd. (207940) de 2014 à 2026
Actions en circulation à la fin de chaque année
| Année | Actions en circulation | Changez |
|---|---|---|
| 2026 (TTM) | 46.61M | 0.79% |
| 2025 | 46.24M | -0.11% |
| 2024 | 46.29M | 0.00% |
| 2023 | 46.29M | 2.05% |
| 2022 | 45.36M | 4.31% |
| 2021 | 43.49M | 0.00% |
| 2020 | 43.49M | 0.00% |
| 2019 | 43.49M | 0.00% |
| 2018 | 43.49M | 0.00% |
| 2017 | 43.49M | 16.56% |
| 2016 | 37.31M | -14.21% |
| 2015 | 43.49M | 0.00% |
| 2014 | 43.49M | 0.00% |
Actions en circulation pour des entreprises similaires ou concurrentes
| Entreprise | Actions en circulation | Différence | Pays |
|---|---|---|---|
| 253.90M | 444.79% |
US
|
|
| 396.00M | 749.69% |
US
|
|
| 478.91M | 927.60% |
AU
|
|
| 0.00 | -100.00% |
BE
|
|
| 62.19M | 33.43% |
NL
|
